NCT00140036已完成4 期
Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 137
- 试验地点
- 35
- 主要终点
- Correlation of genotype with safety and efficacy measures.
研究概览
简要总结
This protocol describes procedures for the collection of blood samples for the intent of determining genetic contribution to the safety and efficacy of CPT/FU/LV.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participation in studies employing treatment with irinotecan and a signed informed consent.
排除标准
- 未提供
结局指标
主要结局
Correlation of genotype with safety and efficacy measures.
次要结局
未报告次要终点
研究者
研究点 (35)
Loading locations...
相似试验
招募中
不适用
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy VolunteersHealthy SubjectHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell NeoplasmImmune System DisorderMalignant NeoplasmNCT03207854University of Southern California500
已完成
不适用
Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082WoundNCT00663780Renovo195
已完成
不适用
Genetic Collection ProtocolLiver DiseasesNCT05272319Arbor Research Collaborative for Health171
已完成
不适用
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood SamplesNo Restrictions on DiagnosisNCT01985919Abramson Cancer Center at Penn Medicine206
招募中
不适用
Multi-analyte Blood Test Clinical TrialHCCHepatocellular CarcinomaLiver CirrhosisLiver CancerNCT05199259Helio Genomics1,200